Aurobindo Pharma announced that its subsidiary CuraTeQ Biologics has received successful trial results for its new bone treatment medicine. The drug, called BP16, is a biosimilar of an existing ...

Pharma stocks such as Sun Pharma, Aurobindo Pharma, Dr Reddy's Lab, Cipla, Gland Pharma, Zydus Lifesciences and Lupin would be in action on Friday after the US President Donald Trump halted ...

Aurobindo Pharma's Bone Treatment Drug Shows Promise in Tests Aurobindo Pharma's subsidiary, CuraTeQ Biologics, has announced successful trial results for its new bone treatment medicine. The drug, ...

Gland Pharma topped the losses with a drop of almost 6 per cent, followed by Aurobindo Pharma, which fell by almost 5 per cent. Biocon's shares fell more than 4 per cent, and Sun Pharma, Lupin, Laurus ...

closely followed by Aurobindo Pharma at 46%. Dr. Reddy’s Laboratories and Lupin also show considerable exposure at 41% and 38% respectively. Sun Pharma and Cipla, two of the biggest names in the ...

Indian Pharmaceutical companies, from Sun Pharma Ltd., to Lupin Ltd., Dr. Reddy's Laboratories Ltd., Aurobindo Pharma Ltd., Gland Pharma Ltd., fell up to 5% on Wednesday, April 9, after US President ...

Word from finale guests Dr Jyoti Bindal, principal of Sri Aurobindo College, shared her insights on the importance of words and language in students' development. "Students should get involved in ...

NEW DELHI: Minister of State for Women and Child Development Savitri Thakur said that the children in India are increasingly eating oily and non-nutritive food, not only increasing their weight ...

India Women have named their 15-member squad for the upcoming tri-nation series against Sri Lanka and South Africa. The big addition in the squad from the ICC Women’s Championship series against ...

India's top billionaires, including Mukesh Ambani and Gautam Adani, faced a combined $10.3 billion hit due to a major stock market crash driven by global trade conflicts and US recession concerns ...

Telangana: Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for Dyrupeg, a pegylated filgrastim biosimilar, to CuraTeQ ...

Aurobindo Pharma announced that its wholly owned step-down subsidiary, CuraTeQ Biologics s.r.o., has received permission from the European Commission (EC) to market Dyrupeg in the European Union. The ...